Advisory Board
The European project AIDER
The composition of the Advisory Board reflects a multidisciplinary approach in line with the cross-cutting nature of the AIDER project. It consists of four members from different countries, representing different areas of expertise related to the project and particularly focused on the translational aspects, including members strongly related to the clinics and acquainted with product commercialization.
Prof. Dimitra Darambara
Has dedicated more than 30 years to innovative research into the conceptual design and realization of emerging quantitative medical imaging techniques and the development of precision novel instrumentation that enables them for the next generation of healthcare hardware. She has significantly advanced the performance evaluation of state-of-the-art imaging systems by combining advanced in-silico methods and task-specific metrics for more precise visualization and quantification of cancerous tissues, aiding in early diagnosis and tailored treatment plans. She implements cutting-edge semiconductor pixellated detectors to advanced prototype systems for cancer-based applications in close collaboration with major healthcare manufacturers, semiconductor detector industrial partners and clinicians bridging the gap between experimental physics and clinical practice, ensuring that new technologies developed in the lab influence the design of clinical products and therefore can be effectively used in hospitals to improve cancer patient outcomes.
Dr. Daniel Gagnon
Obtained his Ph.D. in Biomedical Engineering from the University of Montreal after undergraduate studies in Radiation Physics from Montreal Polytechnique. After an early academic career at the Montreal Heart Institute and the Radiology Department of the University of Montreal, he joined Philips Healthcare, Nuclear Medicine group, in Cleveland as Director of Advanced Development and Clinical Sciences. After 10 years at Philips, he joined the Toshina Medical Research Institute in Chicago (to later become Canon) as Chief Technology Advisor. He then joined Accuray as Senior Director, Imaging Technologies, where he was responsible for merging imaging and Radiation Therapy. He holds 100+ patents in SPECT, PET, PET/CT, PET/MR, CT, and X-ray imaging covering image reconstruction and correction, detector, and system design.
Prof. Sibylle Ziegler
Is a physicist with long-standing experience in detector development for nuclear medicine. Her group developed the first preclinical PET prototype which was based on the individual readout of small LSO crystals with APDs. In clinical nuclear medicine, she has been involved in the characterization of the first whole-body PET/MR scanner. In addition to hardware developments, she also focused on PET reconstruction and quantification in PET and SPECT, mainly on scatter and attenuation correction. Currently, she is involved in total-body PET/CT data analysis using biokinetic modeling of dynamic PET data.
Prof. Frédéric Courbon
Has internationally recognized expertise in innovative imaging devices and dosimetry in nuclear medicine. His clinical and scientific work has long focused on the development, validation, and clinical implementation of advanced PET and SPECT technologies, with a particular emphasis on quantitative imaging and targeted radionuclide therapy.
He has contributed to the evaluation of next-generation imaging systems, dynamic acquisition protocols, and advanced reconstruction and quantification methods aimed at improving accuracy and reproducibility. His experience encompasses personalized dosimetry approaches, including voxel-based and population-based models, to better predict absorbed dose and therapeutic response. Professor Courbon has been actively involved in multicenter clinical trials assessing the impact of innovative imaging and dosimetric tools on treatment optimization and patient safety. Through sustained collaborations with academic, clinical, and industrial partners, he has played a key role in bridging technological innovation with clinical translation in precision nuclear medicine.
Projects AiDER
Contact Us
Phone: (+34) 963 54 38 49
email: hello@aider.com
Parque Científico, Catedrático José Beltrán, 2 E-46980 Paterna, España.
